Cyprus Michael Neoptolemou, managing director at Remedica, takes us through the evolution of one of the leading pharmaceutical companies in Cyprus and outlines their successful business model. Neoptolemou also highlights the key opportunities the recent acquisition by Ascendis Health in 2016 has brought to Remedica and how it will further enhance…
Remedica How do you explain that despite the Bolar exemption, a high number of scientists, a very educated population, and Europe’s lowest tax rate, Cyprus has never been able to attract FDI in either manufacturing or R&D? On the one hand, Cyprus seems an attractive place from a geographical and tax…
See our Cookie Privacy Policy Here